Pharmaceutical Injuries - Trasylol
Have You Sustained Personal Injuries from Medications, Pharmaceuticals, or Chemical Exposure?
Trasylol
Trasylol is an injectable drug also known as aprotonin; it is used during cardiopulmonary bypass surgery in order to inhibit inflammation and prevent blood loss during the operation. Produced by Bayer, Trasylol? was approved in 1993 and marketed to be a safe and vital component of bypass and other heart surgeries. Millions of patients have had the drug administered to them during their surgeries.
In January 2006, an article in The New England Journal of Medicine stated that Trasylol? can factor into life-threatening, post-surgery complications. The use of Trasylol? increased the risk of heart attack by 48 percent, heart failure by 109 percent, and stroke by 181 percent, according to a study of 4400 patients. They also found a significant risk of renal (kidney) failure and damage to brain tissue. The FDA issued a public health advisory in February 2006, stating that they will conduct a safety evaluation of Trasylol? to further examine its risks
We are assisting individuals who have confirmed use of Trasylol for CABG, valve, knee or hip replacement procedures, with onset of renal failure iwthin 48 hours of administration which require dialysis of some duration.
You can get a FREE consultation with a leading Trasylol Personal Injury Attorney in your area who can offer sound legal help and assistance with your claim.
| Get a FREE Consultation with a Personal Injury Lawyer! |
|
Please Select Your State:
|
© 2007
| 
